Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Oral Cancer | Research

Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland

Authors: Abdulrahman Sakeen Alkandari, Jemmi Ching Ying Ho, Siu Wai Choi, Peter Thomson

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Objectives

To investigate the risk and prognosis of oral squamous cell carcinoma (SCC) between Indigenous and non-Indigenous populations of Queensland.

Materials and methods

Retrospective analysis of data from the Queensland Cancer Registry (QCR) between the years 1982–2018. Main outcome measures were age at diagnosis and cumulative survival to compare the risk and prognosis of oral SCC between the populations.

Results

9424 patients with self-declared ethnicity were identified with oral SCC from the QCR, with a male to female ratio of 2.56:1. Of these patients, 9132 were non-Indigenous (96.9%) and 292 Indigenous (3.1%). Indigenous people were significantly younger at diagnosis (mean (SD) age 54.3 (10.1) years), compared to 62.0 (12.1) years in non-Indigenous people. Mean survival in the full cohort was 4.3 years (SD: 5.6), with Indigenous people presenting a significant shorter mean survival of 2.0 years (SD: 3.5) when compared with 4.4 years (SD: 5.7) in non-Indigenous people (p < 0.001).

Conclusions

Indigenous Australians are diagnosed at a significantly younger age and present with worse survival and poorer prognosis. Due to missing variables in the Queensland Cancer Registry, it is not possible in the current study to ascertain the scientific or social reasons behind these disparities.

Clinical relevance

Results from this study can inform public policy and raise awareness in Queensland regarding disparity in oral cancer prognosis.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther. 2016;12(2):458–63.CrossRefPubMed Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther. 2016;12(2):458–63.CrossRefPubMed
3.
go back to reference Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21(1):73–9.CrossRefPubMedPubMedCentral Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21(1):73–9.CrossRefPubMedPubMedCentral
7.
go back to reference Mejia G.C, Parker E.J, Jamieson L.M. An introduction to oral health inequalities among Indigenous and non-Indigenous populations. Int Dental J. 2010;60(3S2):212–5. Mejia G.C, Parker E.J, Jamieson L.M. An introduction to oral health inequalities among Indigenous and non-Indigenous populations. Int Dental J. 2010;60(3S2):212–5.
9.
go back to reference Banham D, Roder D, Keefe D, Farshid G, Eckert M, Cargo M, Brown A. Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians. Cancer Epidemiol. 2017;48:131–9.CrossRefPubMed Banham D, Roder D, Keefe D, Farshid G, Eckert M, Cargo M, Brown A. Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians. Cancer Epidemiol. 2017;48:131–9.CrossRefPubMed
10.
go back to reference Zhou W, Liu G, Hung RJ, Haycock PC, Aldrich MC, Andrew AS, Arnold SM, Bickeböller H, Bojesen SE, Brennan P, Brunnström H, Melander O, Caporaso NE, Landi MT, Chen C, Goodman GE, Christiani DC, Cox A, Field JK, Johansson M, Kiemeney LA, Lam S, Lazarus P, Le Marchand L, Rennert G, Risch A, Schabath MB, Shete SS, Tardón A, Zienolddiny S, Shen H, Amos CI. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 2021;148(5):1077–86.CrossRefPubMed Zhou W, Liu G, Hung RJ, Haycock PC, Aldrich MC, Andrew AS, Arnold SM, Bickeböller H, Bojesen SE, Brennan P, Brunnström H, Melander O, Caporaso NE, Landi MT, Chen C, Goodman GE, Christiani DC, Cox A, Field JK, Johansson M, Kiemeney LA, Lam S, Lazarus P, Le Marchand L, Rennert G, Risch A, Schabath MB, Shete SS, Tardón A, Zienolddiny S, Shen H, Amos CI. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 2021;148(5):1077–86.CrossRefPubMed
11.
go back to reference Croese A, Gartrell R, Hiscock R, Lee M, Gibbs P, Faragher I, Yeung J. The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy. Cancer Rep (Hoboken). 2021;4(3): e1346.PubMed Croese A, Gartrell R, Hiscock R, Lee M, Gibbs P, Faragher I, Yeung J. The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy. Cancer Rep (Hoboken). 2021;4(3): e1346.PubMed
12.
go back to reference Ramamurthy P, Sharma D, Thomson P. Oral cancer in Australia: regional and remote perspectives. Faculty Dental J. 2022;13(1):41–5.CrossRef Ramamurthy P, Sharma D, Thomson P. Oral cancer in Australia: regional and remote perspectives. Faculty Dental J. 2022;13(1):41–5.CrossRef
14.
go back to reference Meiklejohn JA, Arley BD, Pratt G, Valery PC, Bernardes CM. “We just don’t talk about it”: Aboriginal and Torres Strait Islander peoples’ perceptions of cancer in regional Queensland. Rural Remote Health. 2019;19(2):4789.PubMed Meiklejohn JA, Arley BD, Pratt G, Valery PC, Bernardes CM. “We just don’t talk about it”: Aboriginal and Torres Strait Islander peoples’ perceptions of cancer in regional Queensland. Rural Remote Health. 2019;19(2):4789.PubMed
15.
go back to reference Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5(Suppl 1):3–29.CrossRefPubMedPubMedCentral Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5(Suppl 1):3–29.CrossRefPubMedPubMedCentral
Metadata
Title
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland
Authors
Abdulrahman Sakeen Alkandari
Jemmi Ching Ying Ho
Siu Wai Choi
Peter Thomson
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11002-1

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine